An Adaptable Nanoprobe Integrated with Quantitative T 1 ‐Mapping MRI for Accurate Differential Diagnosis of Multidrug‐Resistant Lung Cancer
Advanced Healthcare Materials · 2023
DOI: 10.1002/adhm.202300684 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2023. Verfasst von Aijun Shen und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Imaging, Tongji Hospital, School of Medicine, Tongji University, Shanghai, 200065, China. Hauptthemen laut MEDLINE: Lung Neoplasms, Carcinoma, Non-Small-Cell Lung. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities, Shanghai Shenkang Hospital Development Center.
Abstract (Originalsprache)
Multidrug resistance (MDR) is one of the major factors causing failure of non‐small‐cell lung cancer (NSCLC) chemotherapy. Real‐time and accurate differentiation between drug‐resistant and sensitive NSCLC is of primary importance for guiding the subsequent treatments and improving the therapeutic outcome. However, there is no effective method to provide such an accurate differentiation. This study creates an innovative strategy of integrating H 2 O 2 ‐responsive nanoprobes with the quantitative T 1 ‐mapping magnetic resonance imaging (MRI) technique to achieve an accurate differential diagnosis between drug‐resistant and sensitive NSCLC in light of differences in H 2 O 2 content in the tumor microenvironment (TME). The result demonstrates that the synthesized MIL‐53(Fe)@MnO 2 nanocomposites possess an excellent capability of shortening the cancer longitudinal relaxation time (T 1 ) when meeting H 2 O 2 in TME. T 1 ‐mapping MRI could sensitively detect this T 1 variation (about 2.6‐fold that of T1‐weighted imaging (T 1 WI)) to accurately differentiate the H 2 O 2 content between drug‐resistant and sensitive NSCLC. In addition, the quantitative data provided by the T 1 ‐mapping MRI dedicates correct comparison across imaging tests and is more reliable than T 1 WI, thus giving it a chance for precise assessment of the anti‐cancer effect. This innovative strategy of merging TME adaptable nanoprobes with the quantitative MRI technique provides a new approach for the precise diagnosis of multidrug‐resistant NSCLC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Imaging, Tongji Hospital, School of Medicine, Tongji University, Shanghai, 200065, China.
- Department of Gastroenterology, Changhai Hospital, Naval Medical University, Shanghai, 200433, China.
- Department of Materials Science and State Key Laboratory of Molecular Engineering of Polymers, Fudan University, Shanghai, 200438, China.
- Department of Urology, Huashan Hospital, Fudan University, 200040, Shanghai, China.
- Department of Medical Ultrasound, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Tongji University Cancer Center, Shanghai, 200072, China.
ORCID-Profile: Aijun Shen
Förderung
- National Natural Science Foundation of China
- Fundamental Research Funds for the Central Universities
- Shanghai Shenkang Hospital Development Center
- Shanghai "Rising Stars of Medical Talent" Youth Development Program
- Program of Science and Technology Commission of Shanghai Municipality
- Excellent Discipline Reserve Talent Program of Tongji Hospital Affiliated to Tongji University
- Natural Science Foundation of Shanghai
- Shanghai Municipal Commission of Health and Family Planning
Zitieren
APA
Shen, A., Sun, Y., Wang, G., Meng, X., Ren, X., Wan, Q., Lv, Q., Wang, X., Ni, J., Li, M., Ma, X., Xu, Y., Jiang, Y., Wang, F., Cheng, Y., & Wang, P. (2023). An Adaptable Nanoprobe Integrated with Quantitative T 1 ‐Mapping MRI for Accurate Differential Diagnosis of Multidrug‐Resistant Lung Cancer. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202300684
Vancouver
Shen A, Sun Y, Wang G, Meng X, Ren X, Wan Q, et al. An Adaptable Nanoprobe Integrated with Quantitative T 1 ‐Mapping MRI for Accurate Differential Diagnosis of Multidrug‐Resistant Lung Cancer. Advanced Healthcare Materials. 2023. doi:10.1002/adhm.202300684
BibTeX
@article{Shen2023,
author = {Shen, Aijun and Sun, Yanhong and Wang, Gangmin and Meng, Xianfu and Ren, Xihui and Wan, Qingxuan and Lv, Qi and Wang, Xiangbin and Ni, Jiong and Li, Minghua and Ma, Xiaolong and Xu, Yun and Jiang, Yutao and Wang, Fang and Cheng, YingSheng and Wang, Peijun},
title = {An Adaptable Nanoprobe Integrated with Quantitative T 1 ‐Mapping MRI for Accurate Differential Diagnosis of Multidrug‐Resistant Lung Cancer},
journal = {Advanced Healthcare Materials},
year = {2023},
doi = {10.1002/adhm.202300684}
}
EUVIMED